GESTIÓN EN SALUD PÚBLICA: FDA Publishes Revised Draft Guidance for Industry, Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA - Drug Information Update

domingo, 22 de agosto de 2021

FDA Publishes Revised Draft Guidance for Industry, Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA - Drug Information Update

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)